Viewing Study NCT06161051


Ignite Creation Date: 2025-12-24 @ 11:51 PM
Ignite Modification Date: 2025-12-25 @ 9:45 PM
Study NCT ID: NCT06161051
Status: COMPLETED
Last Update Posted: 2023-12-07
First Post: 2023-12-05
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Treatment Patterns and Real-World Clinical Outcomes in Patients With Advanced NSCLC and MET Exon 14 Skipping Mutation in the United States
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module